{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:45:07Z","timestamp":1778841907002,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s13730-021-00630-w","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:14:27Z","timestamp":1626866067000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-7887","authenticated-orcid":false,"given":"Keitaro","family":"Nishizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"630_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10157-012-0593-7","volume":"16","author":"H Yokoyama","year":"2012","unstructured":"Yokoyama H, Taguchi T, Sugiyama H, Sato H, Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry in the Japanese Society of Nephrology. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16:557\u201363. https:\/\/doi.org\/10.1007\/s10157-012-0593-7.","journal-title":"Clin Exp Nephrol"},{"key":"630_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/asn.2004121080","volume":"16","author":"P Ronco","year":"2005","unstructured":"Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol. 2005;16:1205\u201313. https:\/\/doi.org\/10.1681\/asn.2004121080.","journal-title":"J Am Soc Nephrol"},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","volume":"133","author":"N Cooper","year":"2006","unstructured":"Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006;133:364\u201374. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06024.x.","journal-title":"Br J Haematol"},{"key":"630_CR4","first-page":"402","volume":"185","author":"NR Robles","year":"1989","unstructured":"Robles NR, Lopez Gomez JM, Lobos JM, Valderrabano F. Membranous glomerulonephritis associated with idiopathic thrombocytopenic purpura. Rev Clin Esp. 1989;185:402\u20134 (PMID: 2623266).","journal-title":"Rev Clin Esp"},{"key":"630_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000045379","volume":"82","author":"K Tamura","year":"1999","unstructured":"Tamura K, Takagi N, Yabana M, Kihara M, Toya Y, Takizawa T, et al. Nephrotic syndrome due to membranous glomerulonephritis in a patient with idiopathic thrombocytopenic purpura. Nephron. 1999;82:87\u20139. https:\/\/doi.org\/10.1159\/000045379.","journal-title":"Nephron"},{"key":"630_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000045428","volume":"83","author":"K Kano","year":"1999","unstructured":"Kano K, Ito S, Ando T, Arisaka O, Tomita S, Ueda Y. Chronic idiopathic thrombocytopenic purpura in a patient with membranous glomerulonephritis. Nephron. 1999;83:358. https:\/\/doi.org\/10.1159\/000045428.","journal-title":"Nephron"},{"key":"630_CR7","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1016\/s0272-6386(05)90004-8","volume":"37","author":"MB Lande","year":"2001","unstructured":"Lande MB, Thomas GA, Houghton DC. Membranous nephropathy associated with chronic immune thrombocytopenic purpura in childhood. Am J Kid Dis. 2001;37:E40. https:\/\/doi.org\/10.1016\/s0272-6386(05)90004-8.","journal-title":"Am J Kid Dis"},{"key":"630_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/09537104.2010.494744","volume":"21","author":"S Alkindi","year":"2010","unstructured":"Alkindi S, Khan S, Riyami D, Farooqi M, Pathare A. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab. Platelets. 2010;21:575\u20137. https:\/\/doi.org\/10.3109\/09537104.2010.494744.","journal-title":"Platelets"},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/nejmoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321. https:\/\/doi.org\/10.1056\/nejmoa0810457.","journal-title":"N Engl J Med"},{"key":"630_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","volume":"19","author":"H Ohtani","year":"2004","unstructured":"Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfg616.","journal-title":"Nephrol Dial Transplant"},{"key":"630_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10157-013-0930-5","volume":"18","author":"E Muso","year":"2014","unstructured":"Muso E. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol. 2014;18:286\u201390. https:\/\/doi.org\/10.1007\/s10157-013-0930-5.","journal-title":"Clin Exp Nephrol"},{"key":"630_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10157-014-0996-8","volume":"19","author":"E Muso","year":"2015","unstructured":"Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, et al. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol. 2015;19:379\u201386. https:\/\/doi.org\/10.1007\/s10157-014-0996-8.","journal-title":"Clin Exp Nephrol"},{"key":"630_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1365-2141.2003.04509.x","volume":"122","author":"H Chan","year":"2003","unstructured":"Chan H, Moore JC, Finch CN, Warkentin TE, Kelton JG. The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb\/IIIa in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 2003;122:818\u201324. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04509.x.","journal-title":"Br J Haematol"},{"key":"630_CR14","first-page":"655","volume":"54","author":"SL Pfueller","year":"1983","unstructured":"Pfueller SL, Firkin BG, Kerlero de Rosbo N, Riglar A, Mackay IR. Association of increased immune complexes, platelet IgG and serum IgG in chronic active hepatitis. Clin Exp Immunol. 1983;54:655\u201360 (PMID: 6652974; PMCID: PMC1536157).","journal-title":"Clin Exp Immunol"},{"key":"630_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/s0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982;2:1309\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(82)91513-6.","journal-title":"Lancet"},{"key":"630_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.atherosclerosissup.2017.05.028","volume":"30","author":"C Stefanutti","year":"2017","unstructured":"Stefanutti C, Mazza F, Pasqualetti D, Di Giacomo S, Watts GF, Massari MS, et al. Lipoprotein apheresis downregulates IL-1\u03b1, IL-6 and TNF-\u03b1 mRNA expression in severe dyslipidaemia. Atheroscler Suppl. 2017;30:200\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.05.028.","journal-title":"Atheroscler Suppl"},{"key":"630_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/cei.12279","volume":"176","author":"RM Talaat","year":"2014","unstructured":"Talaat RM, Elmaghraby AM, Barakat SS, El-Shahat M. Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin Exp Immunol. 2014;176:291\u2013300. https:\/\/doi.org\/10.1111\/cei.12279.","journal-title":"Clin Exp Immunol"},{"key":"630_CR18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/s-0040-1722186","volume":"121","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xu P, Guo L, Wang H, Min Y, Feng Q, et al. Tumor necrosis factor-\u03b1 blockade corrects monocyte\/macrophage imbalance in primary immune thrombocytopenia. Thromb Haemost. 2021;121:767\u201381. https:\/\/doi.org\/10.1055\/s-0040-1722186.","journal-title":"Thromb Haemost"},{"key":"630_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cyto.2011.08.027","volume":"56","author":"C Stefanutti","year":"2011","unstructured":"Stefanutti C, Morozzi C, Petta A. Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia. Cytokine. 2011;56:842\u20139. https:\/\/doi.org\/10.1016\/j.cyto.2011.08.027.","journal-title":"Cytokine"},{"key":"630_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/ijms22010097","volume":"22","author":"A Di Paola","year":"2020","unstructured":"Di Paola A, Palumbo G, Merli P, Argenziano M, Tortora C, Strocchio L, et al. Effects of eltrombopag on in vitro macrophage polarization in pediatric immune thrombocytopenia. Int J Mol Sci. 2020;22:97. https:\/\/doi.org\/10.3390\/ijms22010097.","journal-title":"Int J Mol Sci"},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1744-9987.2011.00984.x","volume":"15","author":"S Ueda","year":"2011","unstructured":"Ueda S, Sugimoto K, Yanagida H, Fujita S, Miyazawa T, Sakata N, et al. Low-density lipoprotein adsorption therapy can restore drug sensitivity for immunosuppressants via inhibitory effects upon MDR-1 gene expression. Ther Apher Dial. 2011;15:499\u2013503. https:\/\/doi.org\/10.1111\/j.1744-9987.2011.00984.x.","journal-title":"Ther Apher Dial"},{"key":"630_CR22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00467-006-0187-2","volume":"21","author":"A Wasilewska","year":"2006","unstructured":"Wasilewska A, Zoch-Zwierz W, Pietruczuk M, Zalewski G. Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol. 2006;21:1274\u201380. https:\/\/doi.org\/10.1007\/s00467-006-0187-2.","journal-title":"Pediatr Nephrol"},{"key":"630_CR23","first-page":"233","volume":"66","author":"L Schwarzov\u00e1","year":"2018","unstructured":"Schwarzov\u00e1 L, Pirn\u00edk Z, \u0160tecov\u00e1 N. Idiopathic thrombocytopenia refractery to therapy of cyclosporine A in clinical practice\u2014case report. Ceska Slov Farm. 2018;66:233\u20137 (PMID: 29623717).","journal-title":"Ceska Slov Farm"},{"key":"630_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ki.1995.314","volume":"48","author":"L Biancone","year":"1995","unstructured":"Biancone L, Andres G, Ahn H, DeMartino C, Stamenkovic I. Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis. Kidney Int. 1995;48:458\u201368. https:\/\/doi.org\/10.1038\/ki.1995.314.","journal-title":"Kidney Int"},{"key":"630_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2017.92","volume":"13","author":"P Ruggenenti","year":"2017","unstructured":"Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift. Nat Rev Nephrol. 2017;13:563\u201379. https:\/\/doi.org\/10.1038\/nrneph.2017.92.","journal-title":"Nat Rev Nephrol"},{"key":"630_CR26","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2011-11-393975","volume":"119","author":"VL Patel","year":"2012","unstructured":"Patel VL, Mah\u00e9vas M, Lee SY, Stasi R, Cunningham-Rundles S, Godeau B, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012;119:5989\u201395. https:\/\/doi.org\/10.1182\/blood-2011-11-393975.","journal-title":"Blood"},{"key":"630_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/nejmoa1814427","volume":"381","author":"FC Fervenza","year":"2019","unstructured":"Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019;381:36\u201346. https:\/\/doi.org\/10.1056\/nejmoa1814427.","journal-title":"N Engl J Med"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00630-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:55:13Z","timestamp":1643824513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00630-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00630-w","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number: 202046-3) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants (Ethical approval)"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}